Connect with us


Japal received a financing round of €300,000 from investors

The Italian start-up Japal has just closed a financing round of $326,00 (€300,000) from a group of investors. During the first round of equity crowdfunding, back in March 2019, Japal collected $60,000 (€55,000). The e-commerce platform developed by the company is useful for both end users and business customers. The new system has been designed to manage and process a high volume of orders.



This picture show a couple of coins.

Japal, an innovative startup active in e-commerce since 2018, founded by Paolo Broglia and Jacopo Moschini together with Jacopo Paoletti, has received a round of financing of $326,000 (€300,000) from a group of private investors, mainly entrepreneurs.

Get comprehensive access to global crowdfunding business, stock market, finance news, and trending topics with the Born2Invest mobile app. Our companion app gives you access to the latest business headlines and lets you read articles without clutter. You can use the app with no limits on how many articles you can view.

The e-commerce platform Japal is handy for both end-users and business customers

For Japal, which has developed the first Italian e-commerce platform with the aim of supporting medium-large consumer goods companies in the delivery of their products at the home of their customers, this is the second round of investment. The first round of about $60,000 (€55,000) collected with an equity crowdfunding campaign on OpStart was in March 2019, based on a pre-money value of $1.63 million (€1.5 million).

For end-users (B2C) it is the marketplace of consumer products where they can find the full range of brands and where they can do their daily online shopping. For business customers (B2B) it is the outsourced e-commerce service of the big brands where special formats can be found (for example for the Horeca channel) but also where traditional formats without minimum quantities can be bought, all with a dedicated price list. Among the brands present on there is Bonomelli, Cannamela, Petti, Panarello, Dr. Beckmann, Orphea, Podovis, Pearl Drops, Mister Magic, Arbre Magique and many others.

The new round, signed last February, allowed Japal to launch its new custom-made CMS (Content Management System) and an advanced management system for the optimization of processes related to micro picking (i.e. logistics management on single references with barcode readers) and logistics activities, carried out together with its partner Italmondo. The new system has been designed to manage and process a high volume of orders, keeping track of all the information dictated by the type of consumer products. Moreover, thanks to the traffic analysis tools on the platform, it is able to provide its brands with important data on the purchasing behavior of its consumers in real-time.

Japal was born out of the founders’ previous experience

“2019 ended with about $543,000 (€500,000) in revenues and this year we are aiming for one million. Japal was born from the previous experience that my partners and I had when we started working on a similar project for Arbre Magique with MyChicJungle. Then we realized that we were developing a technology that would be useful to many other brands. Soon after, we started to work with Montenegro-Cannamela and to further refine our offer,” Paolo Broglia said.

Broglia, Moschini, and Paoletti added: “In this exceptional historical period we have received many requests for help from the brands to make the delivery of their products to consumers in quarantine due to the COVID-19 safely accessible. We know that our mission in this situation becomes even more important, which is why we are at the forefront to ensure the shipment of essential goods. In addition, together with the Rava Foundation, we have launched a solidarity campaign for the purchase of urgent intensive care equipment to hospitals.”


(Featured image by nattanan23 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Be Beez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Helene Lindbergh is a published author with books about entrepreneurship and investing for dummies. An advocate for financial literacy, she is also a sought-after keynote speaker for female empowerment. Her special focus is on small, independent businesses who eventually achieve financial independence. Helene is currently working on two projects—a bio compilation of women braving the world of banking, finance, crypto, tech, and AI, as well as a paper on gendered contributions in the rapidly growing healthcare market, specifically medicinal cannabis.